Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Mushroom cream soothes baby skin rashes in new study

NCT ID NCT07479004

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a cream paste containing pleuran (a beta-glucan from oyster mushrooms) on 110 children with diaper rash, perioral dermatitis, or neonatal pustulosis. Participants applied the cream 2-3 times daily for up to 2 weeks without other treatments. Researchers measured redness and overall skin improvement, and monitored safety and tolerability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

110 people

The number who actually took part.

Started

May 2024

Finished

Dec 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

3 weeks and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * signed informed consent * age from 3 weeks * at least one of the following diagnoses: perioral dermatitis, diaper dermatitis, neonatal pustulosis Exclusion Criteria: * refused to sign informed consent * application of topical corticosteroids, antihistamines, other immunomodulatory preparations (e.g. beta-glucans) at time of inclusion * using of oral corticosteroids, antihistamines at time of inclusion * known intolerance to any ingredients contained in the investigational product

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diaper dermatitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Dermatitis, Perioral Diaper Rash eosinophilic pustular folliculitis Erythema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • General outpatient clinic for children and adolescents

    Banská Bystrica, 974 01, Slovakia

  • General outpatient clinic for children and adolescents

    Bratislava, 821 01, Slovakia

  • General outpatient clinic for children and adolescents

    Bratislava, 821 07, Slovakia

  • General outpatient clinic for children and adolescents

    Bratislava, 841 01, Slovakia

  • General outpatient clinic for children and adolescents

    Bratislava, 841 07, Slovakia

  • General outpatient clinic for children and adolescents

    Bratislava, 851 01, Slovakia

  • General outpatient clinic for children and adolescents

    Brezno, 977 01, Slovakia

  • General outpatient clinic for children and adolescents

    Dolný Kubín, 026 01, Slovakia

  • General outpatient clinic for children and adolescents

    Dunajská Streda, 929 01, Slovakia

  • General outpatient clinic for children and adolescents

    Košice, 04001, Slovakia

  • General outpatient clinic for children and adolescents

    Martin, 036 01, Slovakia

  • General outpatient clinic for children and adolescents

    Ružomberok, 034 01, Slovakia

  • General outpatient clinic for children and adolescents

    Trnava, 917 01, Slovakia

  • General outpatient clinic for children and adolescents

    Zlaté Moravce, 95301, Slovakia

  • General outpatient clinic for children and adolescents

    Žiar nad Hronom, 96501, Slovakia

More trials for these conditions

Other studies related to the condition(s) this trial covers.